Progressive Stock And 2 Dividend Names For Investors Seeking Reliable Income

Global inflation risks, energy price swings and shifting tariffs are keeping investors on edge, which makes reliable income from dividends especially attractive. The Dividend Powerhouses (3%+ Yield) screener focuses on companies offering yields above 5% that are described as well covered, growing and stable. For investors who want regular cash returns without trying to predict every macro twist, this kind of filter can help narrow the field to income options with some built in resilience. In this article, you will see three of the strongest candidates highlighted from the current Dividend Powerhouses lineup.

Progressive (PGR)

Overview: Progressive is one of the largest US auto insurers, providing coverage for personal vehicles, motorcycles, RVs, boats, homes, renters and small businesses, largely through independent agents as well as online and over the phone. Founded in 1937 and based in Mayfield, Ohio, the company combines traditional insurance products with data driven pricing and telematics programs such as usage based auto policies.

Operations: Progressive generates essentially all of its revenue in the United States, with around US$91.0b in annual revenue tied to domestic insurance and related activities.

Market Cap: US$120.4b

Progressive stands out in this dividend focused screen because it combines a high 34.1% ROE and strong earnings quality with a data heavy underwriting model that many investors see as a competitive edge. Its telematics and analytics help it price risk and control expenses, which matters when underwriting margins come under pressure and earnings are forecast to decline over the next few years. At the same time, an unstable dividend history, insider selling and reliance on external borrowing raise questions about how resilient those cash returns will be. With analysts divided on price targets and underwriting trends in the spotlight after recent results, there is more to unpack before deciding how Progressive fits into an income portfolio.

Progressive’s 34.1% ROE and data heavy underwriting can look like an earnings engine hiding in plain sight, but the real story shows up in the 2 key rewards and 3 important warning signs (1 is major!)

Accenture (ACN)

Overview: Accenture is a global consulting and technology services company that helps large organisations and governments design, build and run their systems, from cloud and cybersecurity through to AI, data and outsourced operations across many sectors.

Operations: Accenture generates most of its revenue from industry groups such as Products (about US$22.3b), Health & Public Service (about US$14.9b), Financial Services (about US$13.8b), Communications, Media & Technology (about US$12.4b) and Resources (about US$9.8b).

Market Cap: US$84.9b

Accenture appears in a dividend screen because it combines a 4.7% yield and ROE of 23.7% with a global client base that is turning to the company for AI, cybersecurity and complex outsourcing projects. At the same time, the stock trades below some estimates of fair value and below many peers on P/E. Earnings slipped 2% last year, net margins eased to 10.7% and management is reshaping a 799,000 strong workforce for an AI heavy future, which involves execution risk and restructuring costs. In addition, there is significant use of external borrowing and softer bookings. Overall, Accenture presents as a higher quality dividend story, but it still warrants closer inspection before being relied on as a core income anchor.

Accenture’s 4.7% yield and global AI pivot could be masking where the real long term value sits. The full story only comes into focus once you see the analyst forecasts for Accenture

Medtronic (MDT)

Overview: Medtronic is a global medical technology company that makes devices such as heart defibrillators and pacemakers, spinal and brain implants, surgical tools, and diabetes management systems that hospitals and doctors use to treat chronic conditions. Its products sit inside operating rooms, intensive care units, and patients’ homes across the United States, Ireland and a wide range of international markets.

Operations: Medtronic generates most of its revenue from Cardiovascular at about US$14.0b, Neuroscience at about US$10.3b, Medical Surgical at about US$8.8b and Other at about US$3.2b, supported by roughly US$18.1b from the United States and US$18.1b from the rest of the world.

Market Cap: US$105.0b

Medtronic offers a mix of a 3.46% dividend yield, global scale in treating chronic diseases and a pipeline in areas like robotics, AI powered surgical tools and neuromodulation, while trading on a P/E below many US medical equipment peers. At the same time, margin pressure, underperforming units such as parts of Diabetes and Neuroscience, product recalls and the complex Diabetes spin off plan mean execution is important from here. For income focused investors, the 49 year track record of dividend increases and recent acquisitions in higher growth niches may be appealing, but the key question is how its pipeline, restructuring and risks compare when you look at the detailed forecasts, valuation work and risk checks that sit behind the headline story.

Medtronic’s pipeline in robotics, AI powered tools and neuromodulation could be doing more of the heavy lifting than the headline 3.46% yield suggests, and the full picture only really shows up in the analyst forecasts for Medtronic

The three dividend stocks in this article are only a starting point, with the full Dividend Powerhouses (3%+ Yield) screener surfacing 90 more companies that pair 5%+ yields with equally compelling income narratives. Use Simply Wall St to identify, analyze and filter for the exact catalysts and storylines that matter to you so you can focus on the highest conviction dividend plays in minutes instead of hours.

Take Control of Your Investment Journey

If Accenture or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Beyond These Dividends?

Some of the most interesting stocks start to build breakout momentum while they are still under the radar for now, before the crowd catches on, so consider exploring them early.

• Spot companies quietly building strength with the list of solid balance sheet and fundamentals (48 results) so you can focus on businesses that may better handle shocks while it matters.
• Identify early AI momentum by scanning 64 profitable AI stocks that aren't just burning cash that already generate real earnings, not just promises, and position yourself before sentiment shifts.
• Track power grid upgrades shaping future energy flows using the curated 35 power grid technology and infrastructure stocks and stay close to potential infrastructure candidates before prices move.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com